279 related articles for article (PubMed ID: 17336575)
1. Regulation of nuclear receptor and coactivator functions by the carboxyl terminus of ubiquitin-conjugating enzyme 9.
Chang YL; Huang CJ; Chan JY; Liu PY; Chang HP; Huang SM
Int J Biochem Cell Biol; 2007; 39(5):1035-46. PubMed ID: 17336575
[TBL] [Abstract][Full Text] [Related]
2. Identification of a non-covalent ternary complex formed by PIAS1, SUMO1, and UBC9 proteins involved in transcriptional regulation.
Mascle XH; Lussier-Price M; Cappadocia L; Estephan P; Raiola L; Omichinski JG; Aubry M
J Biol Chem; 2013 Dec; 288(51):36312-27. PubMed ID: 24174529
[TBL] [Abstract][Full Text] [Related]
3. Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1).
Poukka H; Karvonen U; Janne OA; Palvimo JJ
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14145-50. PubMed ID: 11121022
[TBL] [Abstract][Full Text] [Related]
4. FHL2, UBC9, and PIAS1 are novel estrogen receptor alpha-interacting proteins.
Kobayashi S; Shibata H; Yokota K; Suda N; Murai A; Kurihara I; Saito I; Saruta T
Endocr Res; 2004 Nov; 30(4):617-21. PubMed ID: 15666801
[TBL] [Abstract][Full Text] [Related]
5. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
[TBL] [Abstract][Full Text] [Related]
6. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism.
Spengler ML; Kennett SB; Moorefield KS; Simmons SO; Brattain MG; Horowitz JM
Cell Signal; 2005 Feb; 17(2):153-66. PubMed ID: 15494207
[TBL] [Abstract][Full Text] [Related]
7. A non-covalent interaction between small ubiquitin-like modifier-1 and Zac1 regulates Zac1 cellular functions.
Liu ST; Chang YL; Wang WM; Chung MH; Lin WS; Chou WY; Huang SM
Int J Biochem Cell Biol; 2012 Mar; 44(3):547-55. PubMed ID: 22227369
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional activity of peroxisome proliferator-activated receptor gamma is modulated by SUMO-1 modification.
Ohshima T; Koga H; Shimotohno K
J Biol Chem; 2004 Jul; 279(28):29551-7. PubMed ID: 15123625
[TBL] [Abstract][Full Text] [Related]
9. Ubc9 interacts with chicken ovalbumin upstream promoter-transcription factor I and represses receptor-dependent transcription.
Kobayashi S; Shibata H; Kurihara I; Yokota K; Suda N; Saito I; Saruta T
J Mol Endocrinol; 2004 Feb; 32(1):69-86. PubMed ID: 14765993
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of small ubiquitin-like modifier (SUMO)-ylation of the androgen receptor in the control of cooperativity on selective versus canonical response elements.
Callewaert L; Verrijdt G; Haelens A; Claessens F
Mol Endocrinol; 2004 Jun; 18(6):1438-49. PubMed ID: 15031320
[TBL] [Abstract][Full Text] [Related]
11. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity.
Sentis S; Le Romancer M; Bianchin C; Rostan MC; Corbo L
Mol Endocrinol; 2005 Nov; 19(11):2671-84. PubMed ID: 15961505
[TBL] [Abstract][Full Text] [Related]
12. Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription.
Poukka H; Aarnisalo P; Karvonen U; Palvimo JJ; Jänne OA
J Biol Chem; 1999 Jul; 274(27):19441-6. PubMed ID: 10383460
[TBL] [Abstract][Full Text] [Related]
13. Coactivation of SF-1-mediated transcription of steroidogenic enzymes by Ubc9 and PIAS1.
Suda N; Shibata H; Kurihara I; Ikeda Y; Kobayashi S; Yokota K; Murai-Takeda A; Nakagawa K; Oya M; Murai M; Rainey WE; Saruta T; Itoh H
Endocrinology; 2011 Jun; 152(6):2266-77. PubMed ID: 21467194
[TBL] [Abstract][Full Text] [Related]
14. BS69 undergoes SUMO modification and plays an inhibitory role in muscle and neuronal differentiation.
Yu B; Shao Y; Zhang C; Chen Y; Zhong Q; Zhang J; Yang H; Zhang W; Wan J
Exp Cell Res; 2009 Dec; 315(20):3543-53. PubMed ID: 19766626
[TBL] [Abstract][Full Text] [Related]
15. Dynamin interacts with members of the sumoylation machinery.
Mishra RK; Jatiani SS; Kumar A; Simhadri VR; Hosur RV; Mittal R
J Biol Chem; 2004 Jul; 279(30):31445-54. PubMed ID: 15123615
[TBL] [Abstract][Full Text] [Related]
16. Enhanced detection of in vivo SUMO conjugation by Ubc9 fusion-dependent sumoylation (UFDS).
Niedenthal R
Methods Mol Biol; 2009; 497():63-79. PubMed ID: 19107411
[TBL] [Abstract][Full Text] [Related]
17. SUMO: getting it on.
Anckar J; Sistonen L
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1409-13. PubMed ID: 18031233
[TBL] [Abstract][Full Text] [Related]
18. Purification and activity assays for Ubc9, the ubiquitin-conjugating enzyme for the small ubiquitin-like modifier SUMO.
Yunus AA; Lima CD
Methods Enzymol; 2005; 398():74-87. PubMed ID: 16275321
[TBL] [Abstract][Full Text] [Related]
19. Coactivation of the N-terminal transactivation of mineralocorticoid receptor by Ubc9.
Yokota K; Shibata H; Kurihara I; Kobayashi S; Suda N; Murai-Takeda A; Saito I; Kitagawa H; Kato S; Saruta T; Itoh H
J Biol Chem; 2007 Jan; 282(3):1998-2010. PubMed ID: 17105732
[TBL] [Abstract][Full Text] [Related]
20. Enhanced SUMOylation of proteins containing a SUMO-interacting motif by SUMO-Ubc9 fusion.
Kim ET; Kim KK; Matunis MJ; Ahn JH
Biochem Biophys Res Commun; 2009 Oct; 388(1):41-5. PubMed ID: 19635459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]